Patients with community acquired pneumonia must often be treated in the absence of a definitive microbiologic diagnosis. The mortality associated with pulmonary infection is due to nosocornial penumonia, community-acquired pneumonia requiring hospitalization has had mortalities of 5-150/o in recent series.,_, In the elderly mortality may approach 300Jo,' and in patients requiring admission to the Intensive Care Unit, community-acquired penumonia may be fatal in over 50070 of individuals.
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marize the pertinent considerations essential in the initial selection of antimicrobial therapy in the adult patient with community-acquired pneumonia.
Microbiologic considerations
The most important consideration in selecting initial antibiotic therapy for patients with communityacquired pneumonia is the etiologic agent responsible for the infection. Data from 14 series reported in the 1980's regarding the etiology of community-acquired pneumonia are summarized in Table t .t•J-7•'• 11 -11 Although the prevalence of each pathogen varies from one series to another, it is apparent that streptococcus pneumoniae remain the most common etiologic agent. Equally apparent is the significant percentage of cases in most studies in which no etiologic agent was identified.
The incidence of mycoplasma pneumonia is variable with epidemics occurring every four to eight years. 11 Sporadic disease may occur throughout the year, but epidemic mycoplasma pneumonia occurs more commonly in the summer and fall. The variability in the prevalence of Legionellosis from one geographic area to another is striking. Legionnaires' disease occurs predominantly in late summer and early autumn. Sporadic Legionnaires' disease occurs with higher frequency in males; alcoholics; and in patients with underlying COPD, diabetes mellitus, renal failure, and malignancy. u Residents near excavation sites or occupational exposure as construction work are also predisposing factors.
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Staphylococcus aureus is an uncommon cause of community-acquired pneumonia, accounting for 1-80'/o of cases. It is most commonly encountered in patients with recent influenza or in intravenous drug users with right-sided bacterial endocarditis. Haemophilus influenzae is responsible for 1-15 % of cases is a frequently recognized cause of pneumonia in patients with underlying chronic obstructive Uncommon causes of community-acquired pneumonia include Chlamydia psittaci, Coxiella burnettii, fungi, and Mycobacterium tuberculosis. Of note is the observation that Mycobacterium tuberculosis accounted for lOo/o of cases of community-acquired pneumonia in one recent series from France. 3 Mixed aerobic and anaerobic pneumonia arising in the setting of aspiration may be encountered in elderly or debilitated patients. Residents of chronic care facilities may be colonized with enteric gram negative bacilli in their oropharynx and present with necrotizing gram negative penumonia following aspiration. 22 Gram negative bacilli are relatively uncommon causes of community-acquired pneumonia in healthy immunocompetent individuals in most series in the past decade. Chlamydia TW AR and Branhamella catarrhalis are recently recognized causes of community-acquired pneumonia. 17 •2)• 14 The precise prevalence of these infections remains to be determined. They are probably uncommon, although in one recent study Chlamydia TW AR accounted for 6% of cases of community-acquired pneumonia.
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Epidemics have been described in military conscripts in Scandinavia. 2' 
Clinical manifestations
The clinical features of patients with communityacquired pneumonia may provide useful information in the selection of empiric antibiotic therapy. Community-acquired pneumonia may be divided into typical bacterial penumonia and atypical pneumonia. The major differences between these two syndromes are summarized in Table 2 .
Typical bacterial pneumonia is unsually charcterized by the sudden onset of fever, chills, pleuritic chest pain, and a producitve couth. Streptococcus pneumoniae is the most common etiologic agent, although other potential pathogens include Haemophilus influenzae (especially in the elderly patient with COPD}, Legionella species, gram negative bacilli, and Staphylococcus aureus (often in the setting of previous influenza). Aspiration pneumonia may also present as a "typical" bacterial penumonia. By contrast, the atypical pneumonia syndrome usually presents with subacute onset of fever, constitutional symptoms, and non-productive cough. Headache may be prominent and cough is a minor complaint at the outset, but predominates with time. The most common pathogens include Mycoplasma pneumoniae, numerous viruses, and Legionella species. Uncommon causes include Chlamydia psittaci , Chlamydia TW AR, Coxiella burenetii (the etiologic agent of Q Fever}, Mycobacterium tuberculosis, and several fungi including Histoplasma capsulatum and Coccidioides immitis.
A number of epidemiologic factors in a patient's history may provide clues to the etiologic diagnosis of community-acquired pneumonia. A careful travel, occupational, and exposure history is essential in every patient presenting with pneumonia, since this may reveal exposure to unusual pathogens such as Chlamydia psittaci and Coxiella burnetii . Psittacosis is acquired through exposure to infected birds such as parrots, turkeys, cockatiels, and canaries. Q fever is contracted from the secretions of infected cattle, sheep, or goats.
Pneumonia presenting in the peak of influenza season in the winter should alert one to the possibility of Staphylococcus aureus. Pneumonia in a young person in an institutional setting, such as a military barracks or school dormitory, should raise the possibilities of Mycoplasma pneumoniae or Chlamydia TW AR pneumonia. Nursing home patients or other individuals with obtundation or impaired gag reflexes are predisposed to aspiration Page 14 -JIMA: Volume 23, 1991 Pleurisy uncommon Patchy infiltrates, often lower lobe < 10,000 in 800/o pneumonia with aerobic and anaerobic mouth flora.
Risk factors for infection with the human immunodeficiency virus (HIV) should be elicited in every patient presenting with community-acquired pneumonia, since the differential diagnosis of likely pathogens and empiric therapy are very different in patients with suspected AJDS. This is especially important in young and middle-aged individuals presenting with community-acquired pneumonia. In homosexual males, hemophiliacs, intravenous drug users, and sexually promiscuous individuals, Pneumocystis carinii associted with HIV infection must be entertained in the differential diagnosis. The clinical presentation of pneumocystis pneumonia in AIDS is highly variable and may range from subacute and indolent nonproductive cough and dyspnea on exertion, to a fulminant illness with high fever, constitutional symptoms, cough, and dyspnea.
Certain findings on physical examination may also be helpful in assessing the likelihood of a specific pathogen in patients with community-acquired pneumonia. Relative bradycardia in the absence of underlying heart disease or beta-blockade suggests agents such as Mycoplasma pneumoniae, Legionella species, virus, Chlamydia psittaci, or Chlamydia TW AR. Asplenic or splenectomized patients are predisposed to overwhelming infection with encapsulated organisms such as Streptococcus pneumoniae or Haemophilus influenzae. be considered in such individuals. Bullous myringitis has been associated with mycoplasma pneumonia, 27 although this association bas been disputed in recent years. 21 The presence of Kaposi's sarcoma, thrush, or oral hairy leukoplakia should suggest the presence of underlying infection with the human immunodeficiency virus. If any of these physical findings are present, the differential diagnosis should include Pneumocystis carinii, cytomegal ovirus, and mycobacterial infection as potential causes of penumonia.
Diagnosis
The diagnosis of pneumonia is supported by the radfographic demonstration of pulmonry infiltralion. The radiographic pattern of the infiltrate is sometimes helpful in predicting the likely pathogens. 3 The presence of a lobar infiltrate, large pleural eff usion, or cavitation favors a diagnosis of bacterial pneumonia. Pneumococcal pneumonia usually presents as bronchopneumonia or lobar consolidation. Staphylococcal and gram negative pneumonias may present with consolidation and small areas of cavitation. Mycoplasma pneumonia frequently produces patchy lower lobe infiltrates. Legionella penumonfa often exhibits lobar disease which progresses to involve several additional lobes. Diffuse interstitial infiltrates should suggest viral or Pneumocystis carinii pneumonia.
The initial diagnostic evaluation is dictated by the clinical setting, severity of illness, and presence of underlying disease. Gram stain examination of an adequate sputum specimen is crucial in patients with community-acquired pneumonia. An adequate specimen is defined as one which contains more than 25 white blood cells and fewer than JO epithelial cells per low powered microscopic field. 2 ' If necessary, sputum should be induced by inhalation of nebulized hypertonic saline. If this is unsuccessful, additional invasive diagnostic procedures may be necessary to obtain an adequate specimen of lower respiratory tract secretions.
Empiric antibiotic therapy
The selection of an empiric antibiotic regimen in patients with community-acquired pneumonia depends upon the certainty of the diagnosis and the severity of the illness. Treatment recommendations for respective etiologies of community-acquired pneumonia are summarized in Table 3 . Hospitalized patients with a compatible history, chest radiograph, and sputum gram stain for pneumococcal pneumonia should be treated with penicillin G. Those with uncomplicated pneumonia may receive 600,000 units intravenously Q12 hours. Patients with complicating meningitis, septic arthritis, empyema, or endocarditis required high-dose therapy with 20 million units of intravenous penicillin G per day in divided doses. The penicillin-allergic patient with uncomplicated pneumonia may be treated with erythromycin. Those with concomitant meningitis who are penicillinallergic should receive chloramphenicol or a third generation cephalosporin. ln some areas of the world, penicillin-resistant pneumococci are prevalent. Jo,u This is fortunately quite uncommon in the United States at present. For patients with suspected penicillin-resistant pneumococci, vancomycin appears to be the drug of choice."
Young otherwise healthy patients who present with the atypical pneumonia syndrome may be treated with erythromycin, since this covers mycoplasma and Legionella, as well as the pneumococcus. Patients with mild illnesses may be treated on an outpatient basis if they are compliant and reliable. Sicker patients should be admitted to the hospital for parenteral antibiotic therapy.
Empiric therapy in patients with suspected Haemophilus influenzae pneumonia depends upon the local susceptibility pattern of H. influenzae. In areas where beta-lactamase producing strains of H. influenzae are extremely uncommon, ampicillin is an appropriate empiric choice. On the other hand, in some geographic locales the incidence of betalactamase producing H. influenzae has approached 25 O!o. In such settings, third generation cephalosporins are appropriate choices and are pref er able to second generation drugs such as cephamndole, since they are more resistant to Page 16 -JIMA: Volume 23, 1991 • bacterial beta-lactamases. Of the third generation cephalosporins, cefotaxime, ceftriaxone, and ceftizoxime have comparable in vitro activity against Haemophilus influenzae. The major differences between these three antibiotics are in their pharmacokinetics. Differences in cost may also vary from one institution to another. Any of these drugs would be appropriate empiric choices in patients with sustected H. influenzae pneumonia in areas where beta-lactamase producing strains are commonly encountered.
Patients with post-influenza staphylococcal pneumonia may be treatred with a penicillinaseresistant penicillin such as oxacillin or naf cillin, or a first generation cephalosporin. Vancomycin is the pref erred treatment in the penicillin-allergic patient. Parental drug users with pneumonia should be treated with broad spectrum coverage if a bacterial etiology is suspected. An appropriate empiric regimen would include vancomycin for potential methicillin-resistant Staphylococcus aureus, as well as a third generation cephalosporin, such as ceftazidime, or an aminoglycoside with antipseudomonal activity. If Pneumocystis carinii is a differential diagnostic possibility, trimethoprimsulfamethoxazole or pentamidine should be employed as discussed below.
Erythromycin appears to be the drug of choice for patients with suspected Legionellosis. Doses of 2-4 grams intravenously per day are appropriate, but seriously ill patients with suspected Legionnaires' disease should be treated with erythromycin 1 gm IV Q6H. Some patients will experience tinnitus or impaired hearing on this dose, but this is reversible with dosage reduction or discontinuation of the medication. Rifampin may be added in critically ill patients, although no data clearly demonstrate superior efficacy of two-drug versus single-drug therapy. Doxycycline or tetracycline are alternative agents for the therapy of Legionnaires' disease. Comparative studies have not been done, however, comparing erythromycin with doxycycline or tetracycline.
Community-acquired aspiration pneumonia may be treated with parenteral penicillin or ampicillin in patients who have not been on recent antibiotics or in an institutional setting. Nursing home residents or recently hospitalized patients, in whom oropharyngeal colonization with gram negative bacilli may occur, should receive empiric coverge directed at mouth flora and enteric gram negative bacilU. An appropriate regimen would include penicillin or clindamycin plus a third generation cephalosporin or aminoglycoside. Such a regimen covers Streptococcus pneumoniae, Haemophilus influenzae, mouth anaerobes, and most enteric gram negative rods.
Patients with Pneumocystis carinii penumonia in the setting of AIDS may be treated with either trimethoprim-sulfamethoxazole or pentamicline. Most studies have suggested comparable efficacies of these agents, although a recent randomized prospective trial demonstrated improved survival in trimethoprim-sulfamethoxazone recipients compared with patients receiving pentamidine.
12 Trimethoprimsulfamethoxazone should be adminstered parenterally to patients with moderate or severe Pneumocystis pneumonia at a dose of 15-20 mg/kg/day in two divided doses. Oral therapy is appropriate in patients with mild Pneumocystis or to complete a three week course of therapy in those with more serious disease requiring initial parenteral therapy. Pentamidine is administered at a dose of 4 mg/kg/day by slow intravenous infusion. Side effects are unfortunately common with both medications. Up to 500/o of AIDS patients may experience adverse side effects with trimethoprim-sulf amethoxazole, which most commonly consist of fever, rash, leukopenia, or hepatitis.)] Pentamidine may also produce significant toxicity, including intractable hypoglycemia, renal dysf uncion, hyperglycemia, leukopenia, fever, and hypotension. H The selection of empiric therapy is most difficult in the seriously ill patient with community-acquired pneumonia in whom the diagnosis is uncertain. Such individuals require broad spectrum therapy. A regimen of erythromycin and a third generation cephalosporin provides excellent coverage against the pneumococcus, Mycoplasma pneumoniae, Legionella species, and Haemophllus influen.zae. The third generation cephalosporins also provide reasonable coverage against many enteric gram negative bacilli, although Pseudomonas aeruginosa is not optimally covered by ceftriaxone, cefotaxime, or ceftizoxime. Pseudomonas aeruginosa is an extremely uncommon cause of community-acquired pneumonia, except in patients with underlying cystic fibrosis. If Pseudomonas aeruginosa is a concern, however, an anti-pseudomonal penicillin or third generation cephalosporin, such as ceftazidime, should be employed together with an aminoglycoside. Erythromycin does have some activity against Staphylococcus aureus, although is not a first line drug. lf Staphylococcus aureus is in the differential diagnosis, a semi-synthetic penicillin or vancomycin should be added pending definitive microbiologic information.
The efficacy of newer antibiotics such as imipenem/cilastatin and ciprofloxacin in the treatment of community-acquired pneumonia has been confirmed in several studies. 3M • The major drawbacks of imipenem/cilstatin are its cost and extremely broad spectrum of antimicrobial activity. Most patients with community-acquired pneumonia do not require such broad spectrum therapy. Ciprofloxacin is a potentially attractive agent, since oral therapy is feasible. In vitro testing against Streptococcus pneumoniae and anaerobic mouth flora has disclosed relatively high MICs, raising concern about the utility of ciprofloxacin for penumococcal penumonia or aspiration penumonia.
1 ' Although published studies have suggested favorable results with ciprofloxacin in the treatment of pneumococcal pneumonia, it is our opinion that penicillin or erythromycin remain the agents of choice. The precise role of ciprofloxacin as empiric therapy for community-acquired bacterial pneumonia remains to be defined.
